Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia

Anna Hynd, E.E. Roughead, David Preen, J. Glover, Mahesh Bulsara, J. Semmens

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

To determine whether a 24% increase in patient co-payments in January 2005 and two related co-payment changes for medicines subsidised under the Australian Pharmaceutical Benefits Scheme (PBS) were associated with changes in dispensings in Western Australia (WA).Method: We analysed aggregate monthly prescription counts and defined daily dose per 1,000 population per day (DDD/1,000/day) for atypical antipsychotics, combination asthma medicines, HmgCoA reductase inhibitors (statins) and proton-pump inhibitors (PPIs). Trends pre and post the co-payment increase in January 2005 were compared.Results: In three of the four categories examined, prescription counts were significantly lower following the increase in co-payment thresholds. Compared with dispensings prior to the co-payment increase, prescriptions fell by 8% for combination asthma medicines (p
Original languageEnglish
Pages (from-to)246 - 252
JournalAustralian and New Zealand Journal of Public Health
Volume33
Issue number3
DOIs
Publication statusPublished - 2009

Fingerprint

Dive into the research topics of 'Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia'. Together they form a unique fingerprint.

Cite this